Your SlideShare is downloading. ×
  • Like
Ovarian Cancer
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Ovarian Cancer

  • 667 views
Published

 

Published in Technology , Health & Medicine
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
667
On SlideShare
0
From Embeds
0
Number of Embeds
1

Actions

Shares
Downloads
37
Comments
0
Likes
1

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. STANISLAV ALVARO CARDONA MEDICINE STUDENT INTEGRATED ANALYSES OF THE OVARIAN CANCER GENOME CDK1 INHIBITION SENSITISES AND TUMOURS WITH WILD TYPE BRCA1 TO PARP INHIBITION  
  • 2. FOLDING
  • 3. FOLDING
  • 4. The ovarian cancer is one of the most common in women. Some molecular particles are important to stop it. Inhibitors of the enzyme poly (ADP-ribose polymerase), or PARP, in a study to stop the development of some tumours
  • 5. INTEGRATED ANALYSES OF THE OVARIAN CANCER GENOME   July 4th 2011
  • 6. INTEGRATED ANALYSES OF THE OVARIAN CANCER GENOME   Ovarian cancer is a malignant tumor that arises in any part of the ovary due to mutation and cell proliferation influenced by genetic, environmental or hereditary factors.
  • 7. Its prognosis is good, on the rare occasions when diagnosed early Ovarian cancer is the fifth most common cancer in women in the UK, all over the world, representing approximately 4% of all cancers diagnosed in women INTEGRATED ANALYSES OF THE OVARIAN CANCER GENOME  
  • 8. INTEGRATED ANALYSES OF THE OVARIAN CANCER GENOME   There are several genes involved in the development of this pathology as BRCA1 BRCA2 RB1 NF1 FAT3 CSMD3 GABRA6 CDK12
  • 9. INTEGRATED ANALYSES OF THE OVARIAN CANCER GENOME   This was determined by a genome study of women with ovarian cancer which showed mutations in the mRNA during protein synthesis
  • 10. OBSERVATION I think that this is an important step in the science, because this would be the beginning of the treatment of many pathologies Understanding the genetic material allows find the answers for many medical riddles
  • 11. CDK1 INHIBITION SENSITISES TUMOURS WITH WILD TYPE BRCA1 TO PARP INHIBITION   July 4th 2011
  • 12. CDK1 INHIBITION SENSITISES TUMOURS WITH WILD TYPE BRCA1 TO PARP INHIBITION   Inhibitors of the enzyme poly (ADP-ribose) polymerase, or PARP, are among the most promising drugs currently in development as anti-tumour agents.
  • 13. CDK1 INHIBITION SENSITISES TUMOURS WITH WILD TYPE BRCA1 TO PARP INHIBITION   BRCA1 "breast cancer 1" is a tumor suppressor gene, which regulate the cell cycle and prevent uncontrolled proliferation. CDK1 is a highly conserved protein that functions as a serine / threonine kinase, is encoded by the gene cdc2. Phosphorylation of these proteins control cell cycle progression
  • 14. CDK1 INHIBITION SENSITISES TUMOURS WITH WILD TYPE BRCA1 TO PARP INHIBITION   A combination of a PARP inhibitor with a Cdk1 inhibitor also showed reduced tumour growth and prolonged survival compared to treatment with one or no inhibitors in a mouse model of lung adenocarcinoma.
  • 15. CDK1 INHIBITION SENSITISES TUMOURS WITH WILD TYPE BRCA1 TO PARP INHIBITION   Inhibition of Cdk1 is likely to sensitise tumours with wild type BRCA1 to PARP inhibition, and that a combination of inhibitors of these two enzymes may be a useful treatment for these tumours
  • 16. OBSERVATION That experiments are fundamental to know how the human life is affected begging in the littlest process that define the whole life
  • 17. MEDICAL UTILITY
  • 18. MEDICAL UTILITY The study of the human genome could shed any information about each individual and that is where the solution begins each pathology to develop it.
  • 19. MEDICAL UTILITY New experiments with enzymes have led to cures for various types of cancer, starting with the molecular basis of such tumors which involve cell division and proper transfer of genetic information. Molecular biology is the basis for understanding the processes that lead to cause such conditions, so find a solutions or improvements to the health of people
  • 20. BIBLIOGRAPHY
    • http://www.ecancermedicalscience.com/news-insider-news.asp?itemId=1857
    • http://www.ecancermedicalscience.com/news-insider-news.asp?itemId=1858
    • MARTINEZ SANCHEZ, LINA MARIA. , ET ALL . Biología Molecular, libro de clase. Sexta Edición. Universidad Pontificia Bolivariana. Medellín 2011
  • 21. THANK YOU…